Toxicology

Toxicology is an Elsevier journal founded in 1973 and affiliated with the German Toxicology Society, publishing mechanistic and human-relevant research on exposures to xenobiotic chemicals from the molecular to the organismal level, with a 2025 Journal Impact Factor of 5.2 and a rank of 16th among 106 toxicology journals.《毒理学》（Toxicology）是（Elsevier）出版的期刊，1973 年创刊，与德国毒理学会相关联，刊载从分子到整体水平、与人体健康相关的外源化学物暴露机制研究，2025 年影响因子为 5.2，在 106 种毒理学期刊中列第 16 位。

Scope

• Mechanistic research on the adverse consequences of exposure to xenobiotic chemicals, with an emphasis on human health.外源化学物暴露所致不良后果的机制研究，尤重人体健康。
• Hazard identification and toxicological end points studied across all levels of biological organisation, from molecules to whole organisms.危害识别与毒理学终点的研究，覆盖从分子到整体的各个生物学组织层次。
• Experimental systems ranging from in vivo models and cell culture to organotypic models and computational toxicology.实验体系涵盖体内模型、细胞培养、类器官模型与计算毒理学。
• New approach methodologies and other non-animal methods, assessed on methodological quality, relevance and current best practice.新方法学等非动物方法，按方法学质量、相关性以及现行最佳实践加以评估。
• Original research and review articles on any toxicological topic, with pharmacology-oriented studies explicitly outside the remit.刊载各类毒理学主题的原创研究与综述，偏药理学的稿件不在收稿范围。
• Exposures must be analytically characterised, so uncharacterised mixtures and natural product extracts are not considered.暴露物须经分析表征，成分不明的混合物与天然产物提取物不予受理。
• The readership covers academic, industrial and regulatory toxicologists, from undergraduates to established professionals.读者涵盖学术界、产业界与监管机构的毒理学工作者，从本科生到资深专业人士。

History

• Volume 1 appeared in March 1973 under Elsevier, and the journal is now published from Limerick under the Elsevier Ireland imprint.第 1 卷于 1973 年 3 月由（Elsevier）出版，现以（Elsevier Ireland）名义在爱尔兰利默里克出版。
• The journal is affiliated with the German Toxicology Society, whose membership and annual meeting tie into its editorial community.本刊与德国毒理学会相关联，该会会员与年会构成其编辑共同体的重要部分。
• It appeared fortnightly in the early 2020s, issuing 18 volumes in each of 2021 and 2022, before consolidating to about nine volumes a year as articles became continuously published.本刊在 2020 年代初为半月刊，2021 年与 2022 年每年出 18 卷，其后随按篇连续出版而合并为每年约 9 卷。
• Its impact factor moved from 4.221 in 2021 and 4.571 in 2022 to 4.6 in 2024 and 5.2 in 2025, when it ranked 16th of 106 titles in toxicology and 62nd of 356 in pharmacology and pharmacy.影响因子由 2021 年的 4.221、2022 年的 4.571 变动至 2024 年的 4.6 与 2025 年的 5.2，2025 年在 106 种毒理学期刊中列第 16 位，在 356 种药理学与药学刊物中列第 62 位。
• Authors may publish open access for an article processing charge of 4,300 US dollars, while the subscription route carries no publication fee.作者可选择以 4300 美元的文章处理费开放获取发表，走订阅路径则不收取发表费用。
• Recent special issues have addressed new approach methodologies, hepatotoxicity and animal-free prediction models, and exposures linked to electronic waste.近年专题涉及新方法学、肝毒性及无动物预测模型，以及电子废弃物相关暴露。

Editors

• Mathieu Vinken of the Vrije Universiteit Brussel in Belgium is Editor-in-Chief and a European Registered Toxicologist working on in vitro and computational toxicology.现任主编为比利时（Vrije Universiteit Brussel）的（Mathieu Vinken），系欧洲注册毒理学家，研究体外与计算毒理学。
• Associate editors are Emanuela Corsini of the University of Milan, Neill Liptrott of the University of Liverpool, Hilmi Orhan of Ege University, Nan Sang of Shanxi University and Marize Campos Valadares of the Federal University of Goias.副编辑包括（University of Milan）的（Emanuela Corsini）、（University of Liverpool）的（Neill Liptrott）、（Ege University）的（Hilmi Orhan）、（Shanxi University）的（Nan Sang）以及（Federal University of Goias）的（Marize Campos Valadares）。
• Kendall B. Wallace of the University of Minnesota Medical School in Duluth serves as Emeritus Editor.（University of Minnesota Medical School）杜鲁斯校区的（Kendall B. Wallace）担任荣休编辑。
• The board has 60 editors from 19 countries, led by the United States with 25 members, followed by Germany and the United Kingdom with five each and Canada and China with four each.编委会由 19 个国家的 60 位编辑组成，美国以 25 人居首，德国与英国各 5 人，加拿大与中国各 4 人。
• Every paper is peer reviewed, with a median of two days to a first decision, 23 days to a decision after review and 62 days to acceptance.所有论文均经同行评审，初审决定中位时间为 2 天，外审后决定为 23 天，至录用为 62 天。
• Authors must state the experimental system, dose and duration in the abstract and justify their relevance to human exposure in the methods, identifying chemicals by CAS number, source and purity.作者须在摘要中说明实验体系、剂量与暴露时长，并在方法部分论证其与人体暴露的相关性，同时以（CAS）号、来源与纯度标明所用化学物。